Pilot Analysis of Late Conversion to Belatacept in Kidney Transplant Recipients for Biopsy-Proven Chronic Tacrolimus Toxicity.

Shruti GuptaIvy RosalesDavid Wojciechowski

Published in: Journal of transplantation (2018)

While this study was limited by a small number of patients, belatacept conversion stabilized eGFR at all time points in patients with late allograft function due to chronic tacrolimus toxicity, with a trend towards increased eGFR at 3 months.

Keyphrases

small cell lung cancer
epidermal growth factor receptor
end stage renal disease
tyrosine kinase
ejection fraction
newly diagnosed
oxidative stress
prognostic factors
peritoneal dialysis
randomized controlled trial
study protocol
ultrasound guided
patient reported outcomes
patient reported